Date | Time | Source | Announcement |
---|---|---|---|
19 Dec 2006 | 07:00 AM | Director/PDMR Shareholding | |
19 Dec 2006 | 07:00 AM | Director/PDMR Shareholding | |
14 Dec 2006 | 07:00 AM | Re Exercise of Warrants | |
08 Dec 2006 | 04:21 PM | Holding(s) in Company | |
07 Dec 2006 | 11:21 AM | Director/PDMR S/hldg-Replace | |
07 Dec 2006 | 07:01 AM | Director/PDMR Shareholding | |
07 Dec 2006 | 07:01 AM | Director/PDMR Shareholding | |
07 Dec 2006 | 07:01 AM | Director/PDMR Shareholding | |
07 Dec 2006 | 07:01 AM | Director/PDMR Shareholding | |
07 Dec 2006 | 07:01 AM | Director/PDMR Shareholding | |
07 Dec 2006 | 07:01 AM | Director/PDMR Shareholding | |
06 Dec 2006 | 07:00 AM | Files IND Application | |
06 Dec 2006 | 07:00 AM | Interim Results | |
30 Nov 2006 | 07:00 AM | Re Agreement | |
22 Nov 2006 | 04:07 PM | Notice of Results | |
20 Nov 2006 | 07:00 AM | Market Launch of ReNcell | |
15 Nov 2006 | 07:00 AM | Exercise of Warrants | |
09 Oct 2006 | 09:50 AM | To Present Data in October | |
21 Sep 2006 | 11:49 AM | Re: Warrant Holder Meeting | |
21 Sep 2006 | 11:45 AM | AGM Statement | |
19 Sep 2006 | 03:39 PM | Issue of Equity | |
04 Sep 2006 | 05:31 PM | Director/PDMR Shareholding | |
04 Sep 2006 | 05:31 PM | Director/PDMR Shareholding | |
04 Sep 2006 | 05:23 PM | Director/PDMR Shareholding | |
04 Sep 2006 | 05:18 PM | Director/PDMR Shareholding | |
30 Aug 2006 | 12:03 PM | Holding(s) in Company | |
30 Aug 2006 | 11:57 AM | Holding(s) in Company | |
23 Aug 2006 | 03:19 PM | AGM | |
23 Aug 2006 | 07:00 AM | Re: Clinical Investigator | |
06 Jul 2006 | 10:30 AM | Holding(s) in Company | |
29 Jun 2006 | 02:21 PM | Holding(s) in Company | |
29 Jun 2006 | 07:00 AM | Research Update | |
28 Jun 2006 | 07:00 AM | Re Placing | |
28 Jun 2006 | 07:00 AM | Final Results | |
26 Jun 2006 | 03:27 PM | Notice of Results | |
05 Jun 2006 | 07:00 AM | Conference | |
11 May 2006 | 02:35 PM | Holding(s) in Company | |
26 Apr 2006 | 05:17 PM | Director/PDMR Shareholding | |
26 Apr 2006 | 05:13 PM | Director/PDMR Shareholding | |
26 Apr 2006 | 05:09 PM | Director/PDMR Shareholding | |
26 Apr 2006 | 05:03 PM | Director/PDMR Shareholding | |
26 Apr 2006 | 04:59 PM | Director/PDMR Shareholding | |
18 Apr 2006 | 07:01 AM | Re Agreement | |
18 Apr 2006 | 07:01 AM | Re Agreement | |
10 Apr 2006 | 01:52 PM | Holding(s) in Company | |
05 Apr 2006 | 09:08 AM | Intention to raise funds | |
04 Apr 2006 | 09:52 AM | Research Update | |
08 Mar 2006 | 07:32 AM | Research Update | |
07 Mar 2006 | 07:00 AM | Re: BioSquare Conference | |
16 Feb 2006 | 07:00 AM | Research Update |
ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug delivery platform with customizable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several exosome producer cell lines, its CustomEX platform can be optimized for specific tissue targets and payloads, leading to improvements in therapeutic outcome and a reduction in off-target effects. It offers a delivery mechanism for a variety of payloads such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. Through its conditionally immortalized induced pluripotent stem cell (iPSC) platform, it has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.
It listed on AIM in 2006 under the ticker RENE.